Achyut Healthcare Valuation
Is 543499 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 543499 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 543499's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 543499's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 543499?
Key metric: As 543499 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 543499's PS Ratio? | |
|---|---|
| PS Ratio | 16.6x |
| Sales | ₹67.81m |
| Market Cap | ₹1.09b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 16x |
| Enterprise Value/EBITDA | -1897.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 543499's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.4x | ||
544143 Royal Sense | 5.2x | n/a | ₹1.0b |
543916 Hemant Surgical Industries | 1.3x | n/a | ₹1.3b |
MADHAVBAUG Vaidya Sane Ayurved Laboratories | 1.7x | n/a | ₹1.5b |
QMSMEDI QMS Medical Allied Services | 1.4x | n/a | ₹2.0b |
543499 Achyut Healthcare | 16.6x | n/a | ₹1.1b |
Price-To-Sales vs Peers: 543499 is expensive based on its Price-To-Sales Ratio (16.6x) compared to the peer average (2.4x).
Price to Sales Ratio vs Industry
How does 543499's PS Ratio compare vs other companies in the IN Healthcare Industry?
| 8 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
MONOPHARMA Mono Pharmacare | 0.5x | n/a | US$6.96m |
542934 Chandra Bhagat Pharma | 0.3x | n/a | US$6.17m |
530697 Zenlabs Ethica | 0.5x | n/a | US$3.11m |
SAROJA Saroja Pharma Industries India | 0.6x | n/a | US$2.76m |
| 8 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: 543499 is expensive based on its Price-To-Sales Ratio (16.6x) compared to the Indian Healthcare industry average (4.1x).
Price to Sales Ratio vs Fair Ratio
What is 543499's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 16.6x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 543499's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Medico Intercontinental
₹557.2m
Trades in pharmaceutical products.
539938
₹61.29
7D
33.1%
1Y
-27.8%
Dr Lalchandani Labs
₹81.2m
Provides diagnostic and related healthcare tests and services in India.
541299
₹18.73
7D
4.1%
1Y
-46.5%
N G Industries
₹566.9m
Provides various healthcare services in India.
530897
₹168.05
7D
0.2%
1Y
2.7%